← Back to search

Astraea

Agents that accelerate clinical trials.

Y CombinatorSpring 2026ActiveB2BArtificial IntelligenceSaaSHealth Tech

What they do

Problem

Clinical trial sponsors spend months on manual biometrics programming and data management to turn raw study inputs into compliant, FDA-ready outputs.

Solution

Astraea provides an automated, auditable platform that normalizes clinical trial data and generates CDISC-mapped SDTM/ADaM datasets, TFLs, QC, and revision workflows from raw inputs.

Who it's for

Phase II/III trial sponsors and clinical operations/biometrics teams (often at pharma, biotech, and CROs) who need faster FDA-ready submissions.

Founders

Joshua Wang
Founder

Stanford dropout previously studying CS and Math. Top 250 united states (USAMO) Qualifier, USACO Platinum, first intern at Salient (W23) developing enterprise systems.

Sanmay Sarada
Founder

prev Data Engineer @ Baylor College of Medicine | 4 Publications in Fetal Medicine | CS and Bio at Stanford

Open roles 1

Founding Engineer
San Francisco, CA, US · Full-time · $150K - $300K · 0.50% - 2.00%
Apply ↗

Company timeline

Similar startups